Rosacea Therapeutics Demand to Exceed US$ 2 Billion in 2019 - Persistence Market Research

Rosacea Therapeutics Demand to Exceed US$ 2 Billion in 2019 - Persistence Market Research

PR Newswire

NEW YORK, December 5, 2018

NEW YORK, December 5, 2018 /PRNewswire/ --

PMR's report on global rosacea therapeutics market provides deep-dive insights on the competitive landscape through thorough key company profiling and evaluation of their recent strategic developments

Global Market Study on Rosacea Therapeutics: Emergence of Laser Therapy and Dermabrasion Trending the Global Market

     (Logo: https://mma.prnewswire.com/media/661339/Persistence_Market_Research.jpg )

While these FDA approvals for rosacea therapeutics were registered in 2017, the decently growing rate of the introduction of new FDA-approved drugs is likely to provide a strong push to the revenue expansion of rosacea therapeutics landscape.

Request Sample Report @ https://www.persistencemarketresearch.com/samples/18793

With an expanding rosacea patient pool, most prominently in Europe and North America, the revenue growth prospects for global rosacea therapeutics landscape appear to be on an impressive trajectory over the coming years. In a new intelligence report published by Persistence Market Research (PMR), the global sales of rosacea therapeutics market are likely to receive major benefits from the development of newer formulations of rosacea therapeutics, especially alpha agonists.

A senior research analyst at PMR says, "The largest business opportunity is created by the increasing rosacea instances subsequently followed by inadequate definite curative therapeutics, insufficiently satisfactory as a first-line treatment. Rosacea therapeutics market players are targeting this opportunity leading to strategic new drug developments".

In the consolidated competitive landscape of rosacea therapeutics market, four leading companies account for over 75% share of the total market value, including Pfizer Inc., Teva Pharmaceutical Industries Ltd., Foamix Pharmaceuticals Ltd., and Bayer A.

Rosacea Therapeutics Market Research Report Overview @ https://www.persistencemarketresearch.com/market-research/rosacea-treatment-market.asp

PMR's report on global rosacea therapeutics market provides deep-dive insights on the competitive landscape through thorough key company profiling and evaluation of their recent strategic developments.

"The available range of drugs in rosacea therapeutics necessarily play a palliative, short-term role in addressing the consequences of rosacea. However, the current treatment line still fails to provide a long-term therapy, let alone target the root cause of rosacea. The rosacea therapeutics space has been constantly witnessing R&D efforts with an objective to break through this ever-unmet need, which continues to be hampered by the lack of understanding of the disease itself," explains the analyst, further adding, "There remains a huge gap between the existing rosacea therapeutics and market demand. The rate of treatment is also significantly low, prompting at the upcoming business opportunities for rosacea therapeutics market stakeholders".

Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/methodology/18793

Off-label Pharmaceuticals Favor Sales Growth of Rosacea Therapeutics Landscape

Growing use of off-label drugs is providing a strong impetus to the revenue growth of rosacea therapeutics landscape, as some of them are highly popular for use in refractory cases, including botox, corticosteroids, and sulfacetamides. While the use of off-label drugs prevails for effectively treating rosacea, it is highly non-recommended and invalid according to the FDA and a few European Medicine Agencies. Persistent use off-label, non-recommended drugs continues to elevate the demand prospects for rosacea therapeutics.

Key Insights Drawn from Global Rosacea Therapeutics Market Report 

For more interesting insights on the various other facets of global rosacea therapeutics landscape, feel free to get in touch. Request additional information at media@persistencemarketresearch.com

More from PMR's Life Sciences & Transformational Health Market Intelligence:


Persistence Market Research Overview

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353

Website: https://www.persistencemarketresearch.com 
Email: sales@persistencemarketresearch.com


Voltar noticias em Inglês